<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Andrew Bean, Sebastian Weber, Lukas Widmer" />

<meta name="date" content="2025-04-07" />

<title>Meta-Analytic-Predictive (MAP) approach for dose-toxicity modelling</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
html { -webkit-text-size-adjust: 100%; }
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Meta-Analytic-Predictive (MAP) approach for
dose-toxicity modelling</h1>
<h4 class="author">Andrew Bean, Sebastian Weber, Lukas Widmer</h4>
<h4 class="date">2025-04-07</h4>


<div id="TOC">
<ul>
<li><a href="#introduction" id="toc-introduction">Introduction</a></li>
<li><a href="#application-background" id="toc-application-background">Application background</a>
<ul>
<li><a href="#historical-data" id="toc-historical-data">Historical
data</a></li>
</ul></li>
<li><a href="#derivation-of-map-priors" id="toc-derivation-of-map-priors">Derivation of MAP priors</a>
<ul>
<li><a href="#drug-a-model" id="toc-drug-a-model">Drug A model</a></li>
<li><a href="#drug-b-model" id="toc-drug-b-model">Drug B model</a></li>
<li><a href="#extraction-of-map-priors" id="toc-extraction-of-map-priors">Extraction of MAP priors</a>
<ul>
<li><a href="#mcmc-samples" id="toc-mcmc-samples">MCMC samples</a></li>
<li><a href="#mixture-approximation" id="toc-mixture-approximation">Mixture approximation</a></li>
</ul></li>
</ul></li>
<li><a href="#combination-model-with-map-priors-for-the-new-study" id="toc-combination-model-with-map-priors-for-the-new-study">Combination
model with MAP priors for the new study</a>
<ul>
<li><a href="#robustification" id="toc-robustification">Robustification</a></li>
</ul></li>
<li><a href="#equivalence-of-map-and-mac-advanced" id="toc-equivalence-of-map-and-mac-advanced">Equivalence of MAP and MAC
(advanced)</a></li>
<li><a href="#appendix-model-specification" id="toc-appendix-model-specification">Appendix: Model specification</a>
<ul>
<li><a href="#combination-blrm-new-study-model" id="toc-combination-blrm-new-study-model">Combination BLRM (new study
model)</a>
<ul>
<li><a href="#prior-specification" id="toc-prior-specification">Prior
specification</a></li>
</ul></li>
<li><a href="#meta-analytic-models-for-the-historical-data" id="toc-meta-analytic-models-for-the-historical-data">Meta-analytic
models for the historical data</a>
<ul>
<li><a href="#prior-specification-1" id="toc-prior-specification-1">Prior specification</a></li>
</ul></li>
<li><a href="#hierarchical-model-for-combined-data-mac" id="toc-hierarchical-model-for-combined-data-mac">Hierarchical model for
combined data (MAC)</a></li>
</ul></li>
<li><a href="#session-info" id="toc-session-info">Session Info</a></li>
</ul>
</div>

<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>A common characteristic of modern applications of the Bayesian
Logistic Regression Model (BLRM) for model-based dose escalation is the
availability of relevant historical data on the study treatment(s). For
example, studies testing novel combination therapies may wish to
incorporate available dose-toxicity data on the individual agents from
single-agent dose escalation trials.</p>
<p>There are two broad categories for statistical approaches to
this:</p>
<ul>
<li>Meta-Analytic Combined (MAC) approaches use a hierarchical model to
jointly analyze both the historical data and data from the current
study. External data from concurrently running trials may also be
incorporated in such an approach. The <a href="introduction.html">introductory vignette</a> illustrates this
approach.</li>
<li>Meta-Analytic Predictive (MAP) approaches involve two stages. In the
first, an initial hierarchical model is estimated from the historical
data, and from this model one extracts a posterior prediction for the
trial-level parameters in a future trial. The posterior prediction is
then approximated in parametric form which is used as MAP prior in the
future trial.</li>
</ul>
<p>These two approaches are statistically equivalent to each other
(provided the parametric representation of the MAP prior is exact), but
differ in the “modelling workflow.” While the MAC approach is a
prospective approach enabling to include even concurrent data to borrow
from, the MAP approach is retrospective in that the historical data is
summarized once and usually taken as immutable and static. The MAP
approach has the advantage when designing prospectively a future study
that we can pre-specify (and hence document in a statistical analysis
plan) the information borrowed from the historical data and the model
used for the future study becomes structurally simpler, since there is
often no more a need for a hierarchical model structure at that
stage.</p>
<p>The recommended reference for more details on these approaches, how
they relate to each other, and how they are applied in the dose-toxicity
setting is explained in Neuenschwander et al (2016).</p>
<p>In this vignette, we illustrate the implementation of the MAP
approach, and describe its usage for safety monitoring in a realistic
application.</p>
<p>Initial R session setup:</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="fu">library</span>(OncoBayes2)</span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a><span class="fu">library</span>(RBesT)</span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a><span class="fu">library</span>(posterior)</span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a><span class="fu">library</span>(ggplot2)</span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a><span class="fu">library</span>(dplyr)</span>
<span id="cb1-6"><a href="#cb1-6" tabindex="-1"></a><span class="fu">library</span>(tidyr)</span>
<span id="cb1-7"><a href="#cb1-7" tabindex="-1"></a><span class="fu">library</span>(knitr)</span></code></pre></div>
</div>
<div id="application-background" class="section level1">
<h1>Application background</h1>
<p>We consider a case study involving a Phase-I dose-escalation study of
a combination therapy of two compounds, drug A and drug B, in a
population of adult patients with solid-tumor cancers. The primary
objective of the study was to identify the Maximum Tolerated Dose (MTD)
or Recommended Phase-2 Dose (RP2D) of the combination.</p>
<div id="historical-data" class="section level2">
<h2>Historical data</h2>
<p>In this application, each of the two compounds had previously been
tested in single-agent Phase-I dose escalation studies. MTDs had been
declared for each drug:</p>
<table>
<thead>
<tr class="header">
<th align="left">Drug</th>
<th align="left">Declared MTD</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Drug A</td>
<td align="left">100mg</td>
</tr>
<tr class="even">
<td align="left">Drug B</td>
<td align="left">3mg</td>
</tr>
</tbody>
</table>
<p>These declarations had been made on the basis of the following
dose-toxicity data from the two single-agent studies.</p>
<table>
<caption>Historical data from single-agent study of Drug A</caption>
<thead>
<tr class="header">
<th align="right">Drug A</th>
<th align="right">Evaluable patients</th>
<th align="right">DLTs</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">12.5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="right">25.0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="right">80.0</td>
<td align="right">9</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="right">100.0</td>
<td align="right">23</td>
<td align="right">4</td>
</tr>
<tr class="even">
<td align="right">150.0</td>
<td align="right">3</td>
<td align="right">2</td>
</tr>
</tbody>
</table>
<table>
<caption>Historical data from single-agent study of Drug B</caption>
<thead>
<tr class="header">
<th align="right">Drug B dose</th>
<th align="right">Evaluable patients</th>
<th align="right">DLTs</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">0.125</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="right">0.250</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="right">0.500</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="right">1.000</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="right">2.000</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="right">2.500</td>
<td align="right">7</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="right">3.000</td>
<td align="right">12</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="right">4.000</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>These data were understood to be highly relevant for informing prior
beliefs about the single-agent contributions to the combination toxicity
in the planned study. Therefore a MAP approach was taken to develop
priors for the respective parameters - <span class="math inline">\(\alpha_A\)</span>, <span class="math inline">\(\beta_A\)</span>, <span class="math inline">\(\alpha_B\)</span>, and <span class="math inline">\(\beta_B\)</span> which are obtained by a
meta-analysis of the historical data.</p>
</div>
</div>
<div id="derivation-of-map-priors" class="section level1">
<h1>Derivation of MAP priors</h1>
<p>In the MAP approach, we begin with meta-analytic hierarchical
modelling of the historical data, accounting for the possibility of
between-trial heterogeneity. It is important to note that this is done
even for the case of a single historical study being available. The
information on the between-trial heterogeneity relies in this case on
the priors used for the heterogeneity. In practice log normal priors for
the heterogeneity parameters based on the following table have worked
well in many situations. The approach is to categorize the degree of
heterogeneity between trials in terms of anticipated differences in the
population and further factors which depend on a specific case:</p>
<table>
<caption>Heterogeneity categorization for intercept <span class="math inline">\(\alpha\)</span> and slope <span class="math inline">\(\beta\)</span></caption>
<thead>
<tr class="header">
<th align="left">Heterogeneity degree</th>
<th align="right"><span class="math inline">\(\tau_\alpha\)</span></th>
<th align="right"><span class="math inline">\(\tau_\beta\)</span></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">small</td>
<td align="right">0.125</td>
<td align="right">0.0625</td>
</tr>
<tr class="even">
<td align="left">moderate</td>
<td align="right">0.250</td>
<td align="right">0.1250</td>
</tr>
<tr class="odd">
<td align="left">substantial</td>
<td align="right">0.500</td>
<td align="right">0.2500</td>
</tr>
<tr class="even">
<td align="left">large</td>
<td align="right">1.000</td>
<td align="right">0.5000</td>
</tr>
<tr class="odd">
<td align="left">very large</td>
<td align="right">2.000</td>
<td align="right">1.0000</td>
</tr>
</tbody>
</table>
<p>Here we fit separate models to the historical drug-A and drug-B
single-agent data. Note, equivalently, a single hierarchical
double-combination model without any interaction could have been fit to
those data, and would have produced the same MAP priors for the
drug-level intercepts and slopes. A detailed specification of the models
being fit below is given in the appendix.</p>
<p>In this example we assume that the historical data for drug A comes
from a relatively different population (for example different line of
therapy) and the historical data for drug B stems from a very closely
related patient population. This translates into respective choices for
the between-trial heterogeneity priors according to the table above.</p>
<div id="drug-a-model" class="section level2">
<h2>Drug A model</h2>
<p>Implementation of this meta-analysis of single-agent data is done
using <code>blrm_exnex()</code>. In order to obtain directly a sample of
the MAP prior, we set the <code>sample_map</code> argument to
<code>TRUE</code>.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a><span class="co"># historical data for drug A</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>hist_A <span class="ot">&lt;-</span> <span class="fu">data.frame</span>(</span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>  <span class="at">group_id =</span> <span class="fu">factor</span>(<span class="st">&quot;trial_A&quot;</span>),</span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>  <span class="at">drug_A =</span> <span class="fu">c</span>(<span class="fl">12.5</span>, <span class="dv">25</span>, <span class="dv">50</span>, <span class="dv">80</span>, <span class="dv">100</span>, <span class="dv">150</span>),</span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>  <span class="at">num_patients =</span> <span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">9</span>, <span class="dv">23</span>, <span class="dv">3</span>),</span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>  <span class="at">num_toxicities =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="dv">4</span>, <span class="dv">2</span>)</span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a>)</span>
<span id="cb2-8"><a href="#cb2-8" tabindex="-1"></a></span>
<span id="cb2-9"><a href="#cb2-9" tabindex="-1"></a><span class="co"># reference dose for drug A</span></span>
<span id="cb2-10"><a href="#cb2-10" tabindex="-1"></a>dref_A <span class="ot">&lt;-</span> <span class="dv">80</span></span>
<span id="cb2-11"><a href="#cb2-11" tabindex="-1"></a></span>
<span id="cb2-12"><a href="#cb2-12" tabindex="-1"></a><span class="co"># bivariate normal prior for (intercept, log-slope) </span></span>
<span id="cb2-13"><a href="#cb2-13" tabindex="-1"></a>prior_A <span class="ot">&lt;-</span> <span class="fu">mixmvnorm</span>(<span class="fu">c</span>(<span class="fl">1.0</span>,</span>
<span id="cb2-14"><a href="#cb2-14" tabindex="-1"></a>                       <span class="fu">logit</span>(<span class="fl">0.2</span>), <span class="dv">0</span>,</span>
<span id="cb2-15"><a href="#cb2-15" tabindex="-1"></a>                       <span class="fu">diag</span>(<span class="fu">c</span>(<span class="dv">1</span>, (<span class="fu">log</span>(<span class="dv">4</span>) <span class="sc">/</span> <span class="fl">1.96</span>)<span class="sc">^</span><span class="dv">2</span> ))))</span>
<span id="cb2-16"><a href="#cb2-16" tabindex="-1"></a></span>
<span id="cb2-17"><a href="#cb2-17" tabindex="-1"></a><span class="co"># between-trial heterogeneity is centered on &quot;substantial&quot;</span></span>
<span id="cb2-18"><a href="#cb2-18" tabindex="-1"></a>tau_substantial_prior <span class="ot">&lt;-</span> <span class="fu">mixmvnorm</span>(<span class="fu">c</span>(<span class="fl">1.0</span>,</span>
<span id="cb2-19"><a href="#cb2-19" tabindex="-1"></a>                                     <span class="fu">log</span>(<span class="fu">c</span>(<span class="fl">0.5</span>, <span class="fl">0.25</span>)),</span>
<span id="cb2-20"><a href="#cb2-20" tabindex="-1"></a>                                     <span class="fu">diag</span>(<span class="fu">rep</span>(<span class="fu">log</span>(<span class="dv">2</span>) <span class="sc">/</span> <span class="fl">1.96</span>, <span class="dv">2</span>)<span class="sc">^</span><span class="dv">2</span>)))</span>
<span id="cb2-21"><a href="#cb2-21" tabindex="-1"></a></span>
<span id="cb2-22"><a href="#cb2-22" tabindex="-1"></a><span class="co"># fit the model to the historical data</span></span>
<span id="cb2-23"><a href="#cb2-23" tabindex="-1"></a>map_model_A <span class="ot">&lt;-</span> <span class="fu">blrm_exnex</span>(</span>
<span id="cb2-24"><a href="#cb2-24" tabindex="-1"></a>  <span class="fu">cbind</span>(num_toxicities, num_patients <span class="sc">-</span> num_toxicities) <span class="sc">~</span> </span>
<span id="cb2-25"><a href="#cb2-25" tabindex="-1"></a>    <span class="dv">1</span> <span class="sc">+</span> <span class="fu">log</span>(drug_A <span class="sc">/</span> dref_A) <span class="sc">|</span> </span>
<span id="cb2-26"><a href="#cb2-26" tabindex="-1"></a>    <span class="dv">0</span> <span class="sc">|</span> </span>
<span id="cb2-27"><a href="#cb2-27" tabindex="-1"></a>    group_id,</span>
<span id="cb2-28"><a href="#cb2-28" tabindex="-1"></a>  <span class="at">data =</span> hist_A,</span>
<span id="cb2-29"><a href="#cb2-29" tabindex="-1"></a>  <span class="at">prior_EX_mu_comp =</span> <span class="fu">list</span>(prior_A),</span>
<span id="cb2-30"><a href="#cb2-30" tabindex="-1"></a>  <span class="at">prior_EX_tau_comp =</span> tau_substantial_prior,</span>
<span id="cb2-31"><a href="#cb2-31" tabindex="-1"></a>  <span class="at">prior_EX_prob_comp =</span> <span class="fu">matrix</span>(<span class="dv">1</span>, <span class="at">nrow =</span> <span class="dv">1</span>, <span class="at">ncol =</span> <span class="dv">1</span>),</span>
<span id="cb2-32"><a href="#cb2-32" tabindex="-1"></a>  <span class="at">prior_tau_dist =</span> <span class="dv">1</span>,</span>
<span id="cb2-33"><a href="#cb2-33" tabindex="-1"></a>  <span class="at">sample_map =</span> <span class="cn">TRUE</span></span>
<span id="cb2-34"><a href="#cb2-34" tabindex="-1"></a>)</span></code></pre></div>
</div>
<div id="drug-b-model" class="section level2">
<h2>Drug B model</h2>
<p>Similarly, for drug B:</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a><span class="co"># historical data for drug B</span></span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a>hist_B <span class="ot">&lt;-</span> <span class="fu">data.frame</span>(</span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a>  <span class="at">group_id =</span> <span class="fu">factor</span>(<span class="st">&quot;trial_B&quot;</span>),</span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a>  <span class="at">drug_B =</span> <span class="fu">c</span>(<span class="fl">0.125</span>, <span class="fl">0.25</span>, <span class="fl">0.5</span>, <span class="dv">1</span>, <span class="dv">2</span>, <span class="fl">2.5</span>, <span class="dv">3</span>, <span class="dv">4</span>),</span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a>  <span class="at">num_patients =</span> <span class="fu">c</span>(<span class="dv">2</span>, <span class="dv">1</span>, <span class="dv">2</span>, <span class="dv">2</span>, <span class="dv">3</span>, <span class="dv">7</span>, <span class="dv">12</span>, <span class="dv">3</span>),</span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a>  <span class="at">num_toxicities =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>)</span>
<span id="cb3-7"><a href="#cb3-7" tabindex="-1"></a>)</span>
<span id="cb3-8"><a href="#cb3-8" tabindex="-1"></a></span>
<span id="cb3-9"><a href="#cb3-9" tabindex="-1"></a><span class="co"># reference dose</span></span>
<span id="cb3-10"><a href="#cb3-10" tabindex="-1"></a>dref_B <span class="ot">&lt;-</span> <span class="dv">1</span></span>
<span id="cb3-11"><a href="#cb3-11" tabindex="-1"></a></span>
<span id="cb3-12"><a href="#cb3-12" tabindex="-1"></a><span class="co"># prior for (intercept, log-slope)</span></span>
<span id="cb3-13"><a href="#cb3-13" tabindex="-1"></a>prior_B <span class="ot">&lt;-</span> prior_A</span>
<span id="cb3-14"><a href="#cb3-14" tabindex="-1"></a></span>
<span id="cb3-15"><a href="#cb3-15" tabindex="-1"></a><span class="co"># between-trial heterogeneity is centered on &quot;small&quot;, but with a</span></span>
<span id="cb3-16"><a href="#cb3-16" tabindex="-1"></a><span class="co"># greater degree of uncertainty on this classification</span></span>
<span id="cb3-17"><a href="#cb3-17" tabindex="-1"></a>tau_small_prior <span class="ot">&lt;-</span> <span class="fu">mixmvnorm</span>(<span class="fu">c</span>(<span class="fl">1.0</span>,</span>
<span id="cb3-18"><a href="#cb3-18" tabindex="-1"></a>                               <span class="fu">log</span>(<span class="fu">c</span>(<span class="fl">0.125</span>, <span class="fl">0.0625</span>)),</span>
<span id="cb3-19"><a href="#cb3-19" tabindex="-1"></a>                               <span class="fu">diag</span>(<span class="fu">rep</span>(<span class="fu">log</span>(<span class="dv">4</span>) <span class="sc">/</span> <span class="fl">1.96</span>, <span class="dv">2</span>)<span class="sc">^</span><span class="dv">2</span>)))</span>
<span id="cb3-20"><a href="#cb3-20" tabindex="-1"></a></span>
<span id="cb3-21"><a href="#cb3-21" tabindex="-1"></a><span class="co"># fit model to historical data</span></span>
<span id="cb3-22"><a href="#cb3-22" tabindex="-1"></a>map_model_B <span class="ot">&lt;-</span> <span class="fu">blrm_exnex</span>(</span>
<span id="cb3-23"><a href="#cb3-23" tabindex="-1"></a>  <span class="fu">cbind</span>(num_toxicities, num_patients <span class="sc">-</span> num_toxicities) <span class="sc">~</span> </span>
<span id="cb3-24"><a href="#cb3-24" tabindex="-1"></a>    <span class="dv">1</span> <span class="sc">+</span> <span class="fu">log</span>(drug_B <span class="sc">/</span> dref_B) <span class="sc">|</span> </span>
<span id="cb3-25"><a href="#cb3-25" tabindex="-1"></a>    <span class="dv">0</span> <span class="sc">|</span> </span>
<span id="cb3-26"><a href="#cb3-26" tabindex="-1"></a>    group_id,</span>
<span id="cb3-27"><a href="#cb3-27" tabindex="-1"></a>  <span class="at">data =</span> hist_B,</span>
<span id="cb3-28"><a href="#cb3-28" tabindex="-1"></a>  <span class="at">prior_EX_mu_comp =</span> <span class="fu">list</span>(prior_B),</span>
<span id="cb3-29"><a href="#cb3-29" tabindex="-1"></a>  <span class="at">prior_EX_tau_comp =</span> tau_small_prior,</span>
<span id="cb3-30"><a href="#cb3-30" tabindex="-1"></a>  <span class="at">prior_EX_prob_comp =</span> <span class="fu">matrix</span>(<span class="dv">1</span>, <span class="at">nrow =</span> <span class="dv">1</span>, <span class="at">ncol =</span> <span class="dv">1</span>),</span>
<span id="cb3-31"><a href="#cb3-31" tabindex="-1"></a>  <span class="at">prior_tau_dist =</span> <span class="dv">1</span>,</span>
<span id="cb3-32"><a href="#cb3-32" tabindex="-1"></a>  <span class="at">sample_map =</span> <span class="cn">TRUE</span></span>
<span id="cb3-33"><a href="#cb3-33" tabindex="-1"></a>)</span></code></pre></div>
</div>
<div id="extraction-of-map-priors" class="section level2">
<h2>Extraction of MAP priors</h2>
<p>We now illustrate how these meta-analytic model fits can be used to
produce a parametric MAP prior for the new study intercepts and
slopes.</p>
<div id="mcmc-samples" class="section level3">
<h3>MCMC samples</h3>
<p>Since we called <code>blrm_exnex</code> with the
<code>sample_map=TRUE</code> argument, the posterior now contains the
respective MAP prior MCMC samples for <code>&quot;map_log_beta&quot;</code>
containing for each defined stratum (just one in our case) the MAP
priors in MCMC form for intercept and slope. Here we extract these as
<code>rvar</code> variables which simplifies working with the posterior
draws.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a>rvar_map_log_beta_A <span class="ot">&lt;-</span> <span class="fu">as_draws_rvars</span>(map_model_A, <span class="at">variable=</span><span class="st">&quot;map_log_beta&quot;</span>)<span class="sc">$</span>map_log_beta</span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a>rvar_map_log_beta_B <span class="ot">&lt;-</span> <span class="fu">as_draws_rvars</span>(map_model_B, <span class="at">variable=</span><span class="st">&quot;map_log_beta&quot;</span>)<span class="sc">$</span>map_log_beta</span></code></pre></div>
<p>These are posteriors of 3-dimensional arrays with the dimensions
stratum, drug component and coefficient. In the discussed example only a
single stratum and single drug component (per fitted model) is present
such that we directly select the respective entries of the array here
(note that you may use names to access the respective entries in the
array):</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a>rvar_map_log_beta_A[<span class="dv">1</span>,<span class="st">&quot;log(drug_A/dref_A)&quot;</span>,,drop<span class="ot">=</span><span class="cn">TRUE</span>]</span></code></pre></div>
<pre><code>## rvar&lt;500,4&gt;[2] mean ± sd:
##     intercept     log_slope 
## -1.73 ± 0.82   0.34 ± 0.72</code></pre>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a>rvar_map_log_beta_B[<span class="dv">1</span>,<span class="st">&quot;log(drug_B/dref_B)&quot;</span>,,drop<span class="ot">=</span><span class="cn">TRUE</span>]</span></code></pre></div>
<pre><code>## rvar&lt;500,4&gt;[2] mean ± sd:
##     intercept     log_slope 
## -2.74 ± 0.62  -0.45 ± 0.53</code></pre>
</div>
<div id="mixture-approximation" class="section level3">
<h3>Mixture approximation</h3>
<p>In order to leverage these MAP distributions in analyzing the new
combination study data, we need to operationalize them as parametric
prior distributions for the combination model. This is done by
approximating them with finite mixtures of multivariate normal
distributions, handled by the <code>RBesT</code> function
<code>automixfit()</code>. The <code>automixfit()</code> function
expects the posterior samples in matrix form such that we convert the
draws accordingly:</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" tabindex="-1"></a>map_mix_A <span class="ot">&lt;-</span> <span class="fu">automixfit</span>(<span class="fu">draws_of</span>(rvar_map_log_beta_A[<span class="dv">1</span>,<span class="st">&quot;log(drug_A/dref_A)&quot;</span>,,<span class="at">drop=</span><span class="cn">TRUE</span>]),</span>
<span id="cb9-2"><a href="#cb9-2" tabindex="-1"></a>                        <span class="at">type =</span> <span class="st">&quot;mvnorm&quot;</span>)</span>
<span id="cb9-3"><a href="#cb9-3" tabindex="-1"></a>map_mix_A</span></code></pre></div>
<pre><code>## EM for Multivariate Normal Mixture Model
## Log-Likelihood = -4557.01
## 
## Multivariate normal mixture
## Outcome dimension: 2
## Mixture Components:
##                          comp1       comp2      
## w                         0.56206771  0.43793229
## m[intercept]             -1.88227571 -1.52601780
## m[log_slope]              0.59136954  0.01259954
## s[intercept]              0.68030368  0.92524450
## s[log_slope]              0.59829373  0.73241598
## rho[log_slope,intercept] -0.29870546  0.12832698</code></pre>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" tabindex="-1"></a>map_mix_B <span class="ot">&lt;-</span> <span class="fu">automixfit</span>(<span class="fu">draws_of</span>(rvar_map_log_beta_B[<span class="dv">1</span>,<span class="st">&quot;log(drug_B/dref_B)&quot;</span>,,<span class="at">drop=</span><span class="cn">TRUE</span>]),</span>
<span id="cb11-2"><a href="#cb11-2" tabindex="-1"></a>                        <span class="at">type =</span> <span class="st">&quot;mvnorm&quot;</span>)</span>
<span id="cb11-3"><a href="#cb11-3" tabindex="-1"></a>map_mix_B</span></code></pre></div>
<pre><code>## EM for Multivariate Normal Mixture Model
## Log-Likelihood = -3252.692
## 
## Multivariate normal mixture
## Outcome dimension: 2
## Mixture Components:
##                          comp1       comp2       comp3      
## w                         0.37748737  0.37130812  0.25120451
## m[intercept]             -2.62052660 -2.62077157 -3.09269497
## m[log_slope]             -0.36785969 -0.78173676 -0.08761646
## s[intercept]              0.42385373  0.66468212  0.66682656
## s[log_slope]              0.40861667  0.51156577  0.40148441
## rho[log_slope,intercept] -0.39229212 -0.05739021 -0.50121005</code></pre>
<p>The appropriateness of the parametric approximation to the MCMC
sample can be visually inspected using the <code>plot</code> function
from <code>RBesT</code>:</p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" tabindex="-1"></a><span class="fu">plot</span>(map_mix_A)<span class="sc">$</span>mixpairs</span></code></pre></div>
<pre><code>## Diagnostic plots for mixture multivariate normal densities are experimental.
## Please note that these are subject to changes in future releases.</code></pre>
<p><img role="img" src="data:image/png;base64,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" width="100%" style="display: block; margin: auto;" /></p>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb15-1"><a href="#cb15-1" tabindex="-1"></a><span class="co"># plot(map_mix_B)$mixpairs  # respective plot for drug B</span></span></code></pre></div>
</div>
</div>
</div>
<div id="combination-model-with-map-priors-for-the-new-study" class="section level1">
<h1>Combination model with MAP priors for the new study</h1>
<p>Finally, these mixtures become the prior distributions for the
combination dose-toxicity model in the new study. In this combination
model we now do not need any longer a hierarchical model structure such
we turn this part of the model off by setting
<code>tau_prior_dist=NULL</code>. Note that doing so merely setups the
model to use known heterogeneities <span class="math inline">\(\tau\)</span> which are fixed to a zero mean,
which is what subsequent output will display. A detailed description of
this model is found in appendix.</p>
<div class="sourceCode" id="cb16"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb16-1"><a href="#cb16-1" tabindex="-1"></a><span class="co"># one row of dummy data with number of patients set to zero in order</span></span>
<span id="cb16-2"><a href="#cb16-2" tabindex="-1"></a><span class="co"># to allow the model to be fit</span></span>
<span id="cb16-3"><a href="#cb16-3" tabindex="-1"></a>dummy_data_AB <span class="ot">&lt;-</span> <span class="fu">data.frame</span>(</span>
<span id="cb16-4"><a href="#cb16-4" tabindex="-1"></a>  <span class="at">group_id =</span> <span class="fu">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="at">levels =</span> <span class="fu">c</span>(<span class="st">&quot;trial_AB&quot;</span>)),</span>
<span id="cb16-5"><a href="#cb16-5" tabindex="-1"></a>  <span class="at">drug_A =</span> <span class="dv">1</span>,</span>
<span id="cb16-6"><a href="#cb16-6" tabindex="-1"></a>  <span class="at">drug_B =</span> <span class="dv">1</span>,</span>
<span id="cb16-7"><a href="#cb16-7" tabindex="-1"></a>  <span class="at">num_patients =</span> <span class="dv">0</span>,</span>
<span id="cb16-8"><a href="#cb16-8" tabindex="-1"></a>  <span class="at">num_toxicities =</span> <span class="dv">0</span></span>
<span id="cb16-9"><a href="#cb16-9" tabindex="-1"></a>)</span>
<span id="cb16-10"><a href="#cb16-10" tabindex="-1"></a></span>
<span id="cb16-11"><a href="#cb16-11" tabindex="-1"></a>interaction_prior <span class="ot">&lt;-</span> <span class="fu">mixmvnorm</span>(<span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">0</span>, (<span class="fu">log</span>(<span class="dv">9</span>)<span class="sc">/</span><span class="fl">1.96</span>)<span class="sc">^</span><span class="dv">2</span>))</span>
<span id="cb16-12"><a href="#cb16-12" tabindex="-1"></a></span>
<span id="cb16-13"><a href="#cb16-13" tabindex="-1"></a><span class="co"># fit a double-combination model using the MAP priors</span></span>
<span id="cb16-14"><a href="#cb16-14" tabindex="-1"></a>map_combo <span class="ot">&lt;-</span> <span class="fu">blrm_exnex</span>(</span>
<span id="cb16-15"><a href="#cb16-15" tabindex="-1"></a>  <span class="fu">cbind</span>(num_toxicities, num_patients <span class="sc">-</span> num_toxicities) <span class="sc">~</span></span>
<span id="cb16-16"><a href="#cb16-16" tabindex="-1"></a>    <span class="dv">1</span> <span class="sc">+</span> <span class="fu">I</span>(<span class="fu">log</span>(drug_A <span class="sc">/</span> dref_A)) <span class="sc">|</span></span>
<span id="cb16-17"><a href="#cb16-17" tabindex="-1"></a>    <span class="dv">1</span> <span class="sc">+</span> <span class="fu">I</span>(<span class="fu">log</span>(drug_B <span class="sc">/</span> dref_B)) <span class="sc">|</span></span>
<span id="cb16-18"><a href="#cb16-18" tabindex="-1"></a>    <span class="dv">0</span> <span class="sc">+</span> <span class="fu">I</span>(<span class="dv">2</span> <span class="sc">*</span> (drug_A<span class="sc">/</span>dref_A <span class="sc">*</span> drug_B<span class="sc">/</span>dref_B) <span class="sc">/</span> (<span class="dv">1</span> <span class="sc">+</span> drug_A<span class="sc">/</span>dref_A <span class="sc">*</span> drug_B<span class="sc">/</span>dref_B)) <span class="sc">|</span></span>
<span id="cb16-19"><a href="#cb16-19" tabindex="-1"></a>    group_id,</span>
<span id="cb16-20"><a href="#cb16-20" tabindex="-1"></a>  <span class="at">data =</span> dummy_data_AB,</span>
<span id="cb16-21"><a href="#cb16-21" tabindex="-1"></a>  <span class="at">prior_EX_mu_comp =</span> <span class="fu">list</span>(map_mix_A, map_mix_B), <span class="co"># BVN mixtures for (log-alpha, log-beta) for drugs A and B</span></span>
<span id="cb16-22"><a href="#cb16-22" tabindex="-1"></a>  <span class="at">prior_EX_mu_inter =</span> interaction_prior,</span>
<span id="cb16-23"><a href="#cb16-23" tabindex="-1"></a>  </span>
<span id="cb16-24"><a href="#cb16-24" tabindex="-1"></a>  <span class="co"># shut off hierarchical part of model --</span></span>
<span id="cb16-25"><a href="#cb16-25" tabindex="-1"></a>  <span class="at">prior_tau_dist =</span> <span class="cn">NULL</span></span>
<span id="cb16-26"><a href="#cb16-26" tabindex="-1"></a>)</span></code></pre></div>
<p>This defines the prior distribution for the dose-toxicity
relationship in the novel combination. We can visualize the prior
distributions for the DLT rates:</p>
<div class="sourceCode" id="cb17"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb17-1"><a href="#cb17-1" tabindex="-1"></a>doses <span class="ot">&lt;-</span> <span class="fu">expand_grid</span>(</span>
<span id="cb17-2"><a href="#cb17-2" tabindex="-1"></a>  <span class="at">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</span>
<span id="cb17-3"><a href="#cb17-3" tabindex="-1"></a>  <span class="at">drug_A =</span> <span class="fu">c</span>(<span class="dv">25</span>, <span class="dv">50</span>, <span class="dv">80</span>, <span class="dv">100</span>),</span>
<span id="cb17-4"><a href="#cb17-4" tabindex="-1"></a>  <span class="at">drug_B =</span> <span class="fu">c</span>(<span class="fl">0.5</span>, <span class="dv">1</span>, <span class="dv">3</span>)</span>
<span id="cb17-5"><a href="#cb17-5" tabindex="-1"></a>) <span class="sc">%&gt;%</span></span>
<span id="cb17-6"><a href="#cb17-6" tabindex="-1"></a>  <span class="fu">arrange</span>(drug_B, drug_A)</span>
<span id="cb17-7"><a href="#cb17-7" tabindex="-1"></a></span>
<span id="cb17-8"><a href="#cb17-8" tabindex="-1"></a><span class="fu">plot_toxicity_curve</span>(map_combo,</span>
<span id="cb17-9"><a href="#cb17-9" tabindex="-1"></a>                    <span class="at">newdata =</span> doses,</span>
<span id="cb17-10"><a href="#cb17-10" tabindex="-1"></a>                    <span class="at">x =</span> <span class="fu">vars</span>(drug_A),</span>
<span id="cb17-11"><a href="#cb17-11" tabindex="-1"></a>                    <span class="at">group =</span> <span class="sc">~</span> drug_B)  <span class="sc">+</span></span>
<span id="cb17-12"><a href="#cb17-12" tabindex="-1"></a>  <span class="fu">theme</span>(<span class="at">legend.position=</span><span class="st">&quot;bottom&quot;</span>)</span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" width="100%" style="display: block; margin: auto;" /></p>
<p>We also now have an understanding of which combination doses may have
a high risk of DLTs in terms of the posterior mean,</p>
<div class="sourceCode" id="cb18"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb18-1"><a href="#cb18-1" tabindex="-1"></a>map_summ <span class="ot">&lt;-</span> <span class="fu">summary</span>(map_combo, <span class="at">newdata =</span> doses, <span class="at">interval_prob =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</span>
<span id="cb18-2"><a href="#cb18-2" tabindex="-1"></a><span class="fu">kable</span>(</span>
<span id="cb18-3"><a href="#cb18-3" tabindex="-1"></a>  <span class="fu">cbind</span>(doses[<span class="fu">c</span>(<span class="st">&quot;drug_A&quot;</span>, <span class="st">&quot;drug_B&quot;</span>)], map_summ[<span class="fu">c</span>(<span class="st">&quot;mean&quot;</span>, <span class="st">&quot;sd&quot;</span>, <span class="st">&quot;(0.33,1]&quot;</span>)]),</span>
<span id="cb18-4"><a href="#cb18-4" tabindex="-1"></a>  <span class="at">col.names =</span> <span class="fu">c</span>(<span class="st">&quot;Drug A&quot;</span>, <span class="st">&quot;Drug B&quot;</span>, <span class="st">&quot;mean&quot;</span>, <span class="st">&quot;sd&quot;</span>, <span class="st">&quot;P(DLT rate &gt; 0.33)&quot;</span>),</span>
<span id="cb18-5"><a href="#cb18-5" tabindex="-1"></a>  <span class="at">digits =</span> <span class="dv">2</span>,</span>
<span id="cb18-6"><a href="#cb18-6" tabindex="-1"></a>  <span class="at">caption =</span> <span class="st">&quot;Posterior summary statistics for P(DLT) by dose&quot;</span></span>
<span id="cb18-7"><a href="#cb18-7" tabindex="-1"></a>)</span></code></pre></div>
<table>
<caption>Posterior summary statistics for P(DLT) by dose</caption>
<thead>
<tr class="header">
<th align="right">Drug A</th>
<th align="right">Drug B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">P(DLT rate &gt; 0.33)</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">25</td>
<td align="right">0.5</td>
<td align="right">0.10</td>
<td align="right">0.08</td>
<td align="right">0.01</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">0.5</td>
<td align="right">0.16</td>
<td align="right">0.12</td>
<td align="right">0.08</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">0.5</td>
<td align="right">0.24</td>
<td align="right">0.17</td>
<td align="right">0.26</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">0.5</td>
<td align="right">0.30</td>
<td align="right">0.20</td>
<td align="right">0.37</td>
</tr>
<tr class="odd">
<td align="right">25</td>
<td align="right">1.0</td>
<td align="right">0.13</td>
<td align="right">0.10</td>
<td align="right">0.05</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">1.0</td>
<td align="right">0.19</td>
<td align="right">0.16</td>
<td align="right">0.19</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">1.0</td>
<td align="right">0.28</td>
<td align="right">0.22</td>
<td align="right">0.33</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">1.0</td>
<td align="right">0.33</td>
<td align="right">0.25</td>
<td align="right">0.43</td>
</tr>
<tr class="odd">
<td align="right">25</td>
<td align="right">3.0</td>
<td align="right">0.23</td>
<td align="right">0.19</td>
<td align="right">0.25</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">3.0</td>
<td align="right">0.29</td>
<td align="right">0.25</td>
<td align="right">0.36</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">3.0</td>
<td align="right">0.35</td>
<td align="right">0.29</td>
<td align="right">0.45</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">3.0</td>
<td align="right">0.39</td>
<td align="right">0.31</td>
<td align="right">0.49</td>
</tr>
</tbody>
</table>
<p>and the posterior predictive distribution when assuming a specific
cohort size (6 used as example here):</p>
<div class="sourceCode" id="cb19"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb19-1"><a href="#cb19-1" tabindex="-1"></a>map_pred_summ <span class="ot">&lt;-</span> <span class="fu">summary</span>(map_combo,</span>
<span id="cb19-2"><a href="#cb19-2" tabindex="-1"></a>                         <span class="at">newdata =</span> <span class="fu">mutate</span>(doses, <span class="at">num_toxicities=</span><span class="dv">0</span>, <span class="at">num_patients=</span><span class="dv">6</span>),</span>
<span id="cb19-3"><a href="#cb19-3" tabindex="-1"></a>                         <span class="at">predictive=</span><span class="cn">TRUE</span>, <span class="at">interval_prob =</span> <span class="fu">c</span>(<span class="sc">-</span><span class="dv">1</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="dv">6</span>))</span>
<span id="cb19-4"><a href="#cb19-4" tabindex="-1"></a><span class="fu">kable</span>(</span>
<span id="cb19-5"><a href="#cb19-5" tabindex="-1"></a>  <span class="fu">cbind</span>(doses[<span class="fu">c</span>(<span class="st">&quot;drug_A&quot;</span>, <span class="st">&quot;drug_B&quot;</span>)], map_pred_summ[<span class="fu">c</span>(<span class="st">&quot;(-1,0]&quot;</span>, <span class="st">&quot;(0,1]&quot;</span>, <span class="st">&quot;(1,6]&quot;</span>)]),</span>
<span id="cb19-6"><a href="#cb19-6" tabindex="-1"></a>  <span class="at">col.names =</span> <span class="fu">c</span>(<span class="st">&quot;Drug A&quot;</span>, <span class="st">&quot;Drug B&quot;</span>, <span class="st">&quot;Pr(0 of 6 DLT)&quot;</span>, <span class="st">&quot;Pr(1 of 6 DLT)&quot;</span>, <span class="st">&quot;Pr(&gt;=2 of 6 DLT)&quot;</span>),</span>
<span id="cb19-7"><a href="#cb19-7" tabindex="-1"></a>  <span class="at">digits =</span> <span class="dv">2</span>,</span>
<span id="cb19-8"><a href="#cb19-8" tabindex="-1"></a>  <span class="at">caption =</span> <span class="st">&quot;Posterior predictive summary for Pr(DLT) by dose&quot;</span></span>
<span id="cb19-9"><a href="#cb19-9" tabindex="-1"></a>)</span></code></pre></div>
<table>
<caption>Posterior predictive summary for Pr(DLT) by dose</caption>
<thead>
<tr class="header">
<th align="right">Drug A</th>
<th align="right">Drug B</th>
<th align="right">Pr(0 of 6 DLT)</th>
<th align="right">Pr(1 of 6 DLT)</th>
<th align="right">Pr(&gt;=2 of 6 DLT)</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">25</td>
<td align="right">0.5</td>
<td align="right">0.58</td>
<td align="right">0.29</td>
<td align="right">0.13</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">0.5</td>
<td align="right">0.45</td>
<td align="right">0.31</td>
<td align="right">0.24</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">0.5</td>
<td align="right">0.32</td>
<td align="right">0.29</td>
<td align="right">0.40</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">0.5</td>
<td align="right">0.26</td>
<td align="right">0.26</td>
<td align="right">0.49</td>
</tr>
<tr class="odd">
<td align="right">25</td>
<td align="right">1.0</td>
<td align="right">0.51</td>
<td align="right">0.30</td>
<td align="right">0.19</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">1.0</td>
<td align="right">0.40</td>
<td align="right">0.28</td>
<td align="right">0.31</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">1.0</td>
<td align="right">0.31</td>
<td align="right">0.24</td>
<td align="right">0.44</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">1.0</td>
<td align="right">0.27</td>
<td align="right">0.22</td>
<td align="right">0.51</td>
</tr>
<tr class="odd">
<td align="right">25</td>
<td align="right">3.0</td>
<td align="right">0.37</td>
<td align="right">0.26</td>
<td align="right">0.37</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">3.0</td>
<td align="right">0.34</td>
<td align="right">0.22</td>
<td align="right">0.45</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">3.0</td>
<td align="right">0.29</td>
<td align="right">0.19</td>
<td align="right">0.52</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">3.0</td>
<td align="right">0.26</td>
<td align="right">0.17</td>
<td align="right">0.56</td>
</tr>
</tbody>
</table>
<p>One can see that under the combination one has to decrease the
starting doses well below the declared MTDs for each drug. This is a
consequence of their combination in a new trial such that the
between-trial heterogeneity leads to an increased uncertainty in the
dose-toxicity. The uncertainty is additionally increased through the
introduction of a possible interaction between the two drugs. With the
increased uncertainty in the dose-toxicity curve, the escalation with
overdose criterion EWOC automatically penalizes this lack of knowledge
and requires a conservative starting dose for escalation.</p>
<div id="robustification" class="section level2">
<h2>Robustification</h2>
<p>Direct use of the MAP priors assumes ex-changeability of the
historical and the new trial data. However, this assumption can be
violated such that we may wish to robustify the analysis. This can be
achieved by complementing the MAP prior by a weakly informative mixture
component with some non-zero weight. While the hierarchical model itself
down-weights the historical data already, that is we admit through the
interchangeability differences between trials, adding in this way an
additional weakly informative mixture component leads to an even greater
robustness against a prior-data conflict. This process is sometimes
referred to as “robustification”, and the resulting prior known as a
robust MAP (rMAP) prior. The robustification step is conceptually
equivalent to the use of the EXNEX model under a MAC approach. However,
the two techniques - robustification and EXNEX - differ in that
robustification is a step done after derivation of the MAP prior while
the EXNEX model is a joint model fit.</p>
<p>The robust MAP approach is implemented as:</p>
<div class="sourceCode" id="cb20"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb20-1"><a href="#cb20-1" tabindex="-1"></a><span class="co"># weakly-informative mixture component is chosen here to be equal to</span></span>
<span id="cb20-2"><a href="#cb20-2" tabindex="-1"></a><span class="co"># the priors used in the first place</span></span>
<span id="cb20-3"><a href="#cb20-3" tabindex="-1"></a>weak_A <span class="ot">&lt;-</span> prior_A</span>
<span id="cb20-4"><a href="#cb20-4" tabindex="-1"></a>weak_B <span class="ot">&lt;-</span> prior_B</span>
<span id="cb20-5"><a href="#cb20-5" tabindex="-1"></a></span>
<span id="cb20-6"><a href="#cb20-6" tabindex="-1"></a><span class="co"># adding this to the drug-A and drug-B MAP priors with weight 0.1</span></span>
<span id="cb20-7"><a href="#cb20-7" tabindex="-1"></a>mix_A_robust <span class="ot">&lt;-</span> <span class="fu">mixcombine</span>(map_mix_A, weak_A, <span class="at">weight =</span> <span class="fu">c</span>(<span class="fl">0.9</span>, <span class="fl">0.1</span>))</span>
<span id="cb20-8"><a href="#cb20-8" tabindex="-1"></a>mix_B_robust <span class="ot">&lt;-</span> <span class="fu">mixcombine</span>(map_mix_B, weak_B, <span class="at">weight =</span> <span class="fu">c</span>(<span class="fl">0.9</span>, <span class="fl">0.1</span>))</span>
<span id="cb20-9"><a href="#cb20-9" tabindex="-1"></a></span>
<span id="cb20-10"><a href="#cb20-10" tabindex="-1"></a><span class="co"># robust MAP priors</span></span>
<span id="cb20-11"><a href="#cb20-11" tabindex="-1"></a>mix_robust <span class="ot">&lt;-</span> <span class="fu">list</span>(mix_A_robust, mix_B_robust)</span>
<span id="cb20-12"><a href="#cb20-12" tabindex="-1"></a></span>
<span id="cb20-13"><a href="#cb20-13" tabindex="-1"></a><span class="co"># fit a double-combination model using the rMAP priors</span></span>
<span id="cb20-14"><a href="#cb20-14" tabindex="-1"></a>robust_map_combo <span class="ot">&lt;-</span> <span class="fu">update</span>(map_combo, <span class="at">prior_EX_mu_comp =</span> mix_robust)</span></code></pre></div>
<div class="sourceCode" id="cb21"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb21-1"><a href="#cb21-1" tabindex="-1"></a><span class="co"># disabled plot here</span></span>
<span id="cb21-2"><a href="#cb21-2" tabindex="-1"></a><span class="fu">plot_toxicity_curve</span>(robust_map_combo,</span>
<span id="cb21-3"><a href="#cb21-3" tabindex="-1"></a>                    <span class="at">newdata =</span> doses,</span>
<span id="cb21-4"><a href="#cb21-4" tabindex="-1"></a>                    <span class="at">x =</span> <span class="fu">vars</span>(drug_A),</span>
<span id="cb21-5"><a href="#cb21-5" tabindex="-1"></a>                    <span class="at">group =</span> <span class="sc">~</span> drug_B)  <span class="sc">+</span></span>
<span id="cb21-6"><a href="#cb21-6" tabindex="-1"></a>  <span class="fu">theme</span>(<span class="at">legend.position=</span><span class="st">&quot;bottom&quot;</span>)</span></code></pre></div>
</div>
</div>
<div id="equivalence-of-map-and-mac-advanced" class="section level1">
<h1>Equivalence of MAP and MAC (advanced)</h1>
<p>To demonstrate the equivalence of MAP and MAC, we will illustrate
implementation of the latter approach.</p>
<p>First, we combine the data from all three sources.</p>
<div class="sourceCode" id="cb22"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb22-1"><a href="#cb22-1" tabindex="-1"></a>groups <span class="ot">&lt;-</span> <span class="fu">c</span>(<span class="st">&quot;trial_A&quot;</span>, <span class="st">&quot;trial_B&quot;</span>, <span class="st">&quot;trial_AB&quot;</span>)</span>
<span id="cb22-2"><a href="#cb22-2" tabindex="-1"></a>mac_data <span class="ot">&lt;-</span> <span class="fu">bind_rows_0</span>(hist_A, hist_B)</span>
<span id="cb22-3"><a href="#cb22-3" tabindex="-1"></a>mac_data<span class="sc">$</span>group_id <span class="ot">&lt;-</span> <span class="fu">factor</span>(<span class="fu">as.character</span>(mac_data<span class="sc">$</span>group_id), <span class="at">levels =</span> groups)</span></code></pre></div>
<p>Next, we jointly model all available data using a hierarchical
double-combination BLRM, whose detailed specification can be found in
the appendix. Note that the hierarchical model on the interaction
parameter is not present in the combination model. This cannot be turned
off here such that we assign a negligibly small mean value for the <span class="math inline">\(\tau\)</span> interaction heterogeneity.</p>
<div class="sourceCode" id="cb23"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb23-1"><a href="#cb23-1" tabindex="-1"></a>dummy_tau_inter <span class="ot">&lt;-</span> <span class="fu">mixmvnorm</span>(<span class="fu">c</span>(<span class="fl">1.0</span>, <span class="fu">log</span>(<span class="fl">1E-4</span>), (<span class="fu">log</span>(<span class="dv">2</span>) <span class="sc">/</span> <span class="fl">1.96</span>)<span class="sc">^</span><span class="dv">2</span>))</span>
<span id="cb23-2"><a href="#cb23-2" tabindex="-1"></a></span>
<span id="cb23-3"><a href="#cb23-3" tabindex="-1"></a>num_comp   <span class="ot">&lt;-</span> <span class="dv">2</span> <span class="co"># number of treatment components</span></span>
<span id="cb23-4"><a href="#cb23-4" tabindex="-1"></a>num_inter  <span class="ot">&lt;-</span> <span class="dv">1</span></span>
<span id="cb23-5"><a href="#cb23-5" tabindex="-1"></a>num_groups <span class="ot">&lt;-</span> <span class="fu">length</span>(groups)</span>
<span id="cb23-6"><a href="#cb23-6" tabindex="-1"></a></span>
<span id="cb23-7"><a href="#cb23-7" tabindex="-1"></a>mac_combo <span class="ot">&lt;-</span> <span class="fu">blrm_exnex</span>(</span>
<span id="cb23-8"><a href="#cb23-8" tabindex="-1"></a>  <span class="fu">cbind</span>(num_toxicities, num_patients <span class="sc">-</span> num_toxicities) <span class="sc">~</span></span>
<span id="cb23-9"><a href="#cb23-9" tabindex="-1"></a>    <span class="dv">1</span> <span class="sc">+</span> <span class="fu">I</span>(<span class="fu">log</span>(drug_A <span class="sc">/</span> dref_A)) <span class="sc">|</span></span>
<span id="cb23-10"><a href="#cb23-10" tabindex="-1"></a>    <span class="dv">1</span> <span class="sc">+</span> <span class="fu">I</span>(<span class="fu">log</span>(drug_B <span class="sc">/</span> dref_B)) <span class="sc">|</span></span>
<span id="cb23-11"><a href="#cb23-11" tabindex="-1"></a>    <span class="dv">0</span> <span class="sc">+</span> <span class="fu">I</span>(<span class="dv">2</span> <span class="sc">*</span> (drug_A<span class="sc">/</span>dref_A <span class="sc">*</span> drug_B<span class="sc">/</span>dref_B) <span class="sc">/</span> (<span class="dv">1</span> <span class="sc">+</span> drug_A<span class="sc">/</span>dref_A <span class="sc">*</span> drug_B<span class="sc">/</span>dref_B)) <span class="sc">|</span></span>
<span id="cb23-12"><a href="#cb23-12" tabindex="-1"></a>    group_id,</span>
<span id="cb23-13"><a href="#cb23-13" tabindex="-1"></a>  <span class="at">data =</span> mac_data,</span>
<span id="cb23-14"><a href="#cb23-14" tabindex="-1"></a>  <span class="at">prior_EX_mu_comp =</span> <span class="fu">list</span>(prior_A, prior_B),</span>
<span id="cb23-15"><a href="#cb23-15" tabindex="-1"></a>  <span class="at">prior_EX_tau_comp =</span> <span class="fu">list</span>(tau_substantial_prior, tau_small_prior),</span>
<span id="cb23-16"><a href="#cb23-16" tabindex="-1"></a>  <span class="at">prior_EX_mu_inter =</span> interaction_prior,</span>
<span id="cb23-17"><a href="#cb23-17" tabindex="-1"></a>  <span class="at">prior_EX_tau_inter =</span> dummy_tau_inter,</span>
<span id="cb23-18"><a href="#cb23-18" tabindex="-1"></a>  <span class="at">prior_is_EXNEX_comp =</span> <span class="fu">rep</span>(<span class="cn">FALSE</span>, num_comp),</span>
<span id="cb23-19"><a href="#cb23-19" tabindex="-1"></a>  <span class="at">prior_is_EXNEX_inter =</span> <span class="fu">rep</span>(<span class="cn">FALSE</span>, num_inter),</span>
<span id="cb23-20"><a href="#cb23-20" tabindex="-1"></a>  <span class="at">prior_EX_prob_comp =</span> <span class="fu">matrix</span>(<span class="dv">1</span>, <span class="at">nrow =</span> num_groups, <span class="at">ncol =</span> num_comp),</span>
<span id="cb23-21"><a href="#cb23-21" tabindex="-1"></a>  <span class="at">prior_EX_prob_inter =</span> <span class="fu">matrix</span>(<span class="dv">1</span>, <span class="at">nrow =</span> num_groups, <span class="at">ncol =</span> num_inter),</span>
<span id="cb23-22"><a href="#cb23-22" tabindex="-1"></a>  <span class="at">prior_tau_dist =</span> <span class="dv">1</span></span>
<span id="cb23-23"><a href="#cb23-23" tabindex="-1"></a>)</span></code></pre></div>
<pre><code>## Info: The group(s) trial_AB have undefined strata. Assigning first stratum 1.</code></pre>
<p>Now we compare posterior inference for the DLT rates:</p>
<div class="sourceCode" id="cb25"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb25-1"><a href="#cb25-1" tabindex="-1"></a>mac_summ <span class="ot">&lt;-</span> <span class="fu">summary</span>(mac_combo, <span class="at">newdata =</span> doses, <span class="at">interval_prob =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</span>
<span id="cb25-2"><a href="#cb25-2" tabindex="-1"></a><span class="fu">kable</span>(</span>
<span id="cb25-3"><a href="#cb25-3" tabindex="-1"></a>  <span class="fu">cbind</span>(doses[<span class="fu">c</span>(<span class="st">&quot;drug_A&quot;</span>, <span class="st">&quot;drug_B&quot;</span>)],</span>
<span id="cb25-4"><a href="#cb25-4" tabindex="-1"></a>        map_summ<span class="sc">$</span>mean, mac_summ<span class="sc">$</span>mean,</span>
<span id="cb25-5"><a href="#cb25-5" tabindex="-1"></a>        <span class="fu">abs</span>(map_summ<span class="sc">$</span>mean <span class="sc">-</span> mac_summ<span class="sc">$</span>mean),</span>
<span id="cb25-6"><a href="#cb25-6" tabindex="-1"></a>        map_summ[[<span class="st">&quot;(0.33,1]&quot;</span>]], mac_summ[[<span class="st">&quot;(0.33,1]&quot;</span>]]),</span>
<span id="cb25-7"><a href="#cb25-7" tabindex="-1"></a>  <span class="at">col.names =</span> <span class="fu">c</span>(<span class="st">&quot;Drug A&quot;</span>, <span class="st">&quot;Drug B&quot;</span>,</span>
<span id="cb25-8"><a href="#cb25-8" tabindex="-1"></a>                <span class="st">&quot;MAP mean&quot;</span>, <span class="st">&quot;MAC mean&quot;</span>,</span>
<span id="cb25-9"><a href="#cb25-9" tabindex="-1"></a>                <span class="st">&quot;|MAP mean - MAC mean|&quot;</span>,</span>
<span id="cb25-10"><a href="#cb25-10" tabindex="-1"></a>                <span class="st">&quot;MAP P(DLT rate &gt; 0.33)&quot;</span>, <span class="st">&quot;MAC P(DLT rate &gt; 0.33)&quot;</span>),</span>
<span id="cb25-11"><a href="#cb25-11" tabindex="-1"></a>  <span class="at">digits =</span> <span class="dv">2</span>,</span>
<span id="cb25-12"><a href="#cb25-12" tabindex="-1"></a>  <span class="at">caption =</span> <span class="st">&quot;Posterior summary statistics for P(DLT) by dose&quot;</span></span>
<span id="cb25-13"><a href="#cb25-13" tabindex="-1"></a>)</span></code></pre></div>
<table>
<caption>Posterior summary statistics for P(DLT) by dose</caption>
<colgroup>
<col width="6%" />
<col width="6%" />
<col width="8%" />
<col width="8%" />
<col width="29%" />
<col width="20%" />
<col width="20%" />
</colgroup>
<thead>
<tr class="header">
<th align="right">Drug A</th>
<th align="right">Drug B</th>
<th align="right">MAP mean</th>
<th align="right">MAC mean</th>
<th align="right">|MAP mean - MAC mean|</th>
<th align="right">MAP P(DLT rate &gt; 0.33)</th>
<th align="right">MAC P(DLT rate &gt; 0.33)</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">25</td>
<td align="right">0.5</td>
<td align="right">0.10</td>
<td align="right">0.10</td>
<td align="right">0</td>
<td align="right">0.01</td>
<td align="right">0.02</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">0.5</td>
<td align="right">0.16</td>
<td align="right">0.16</td>
<td align="right">0</td>
<td align="right">0.08</td>
<td align="right">0.09</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">0.5</td>
<td align="right">0.24</td>
<td align="right">0.24</td>
<td align="right">0</td>
<td align="right">0.26</td>
<td align="right">0.25</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">0.5</td>
<td align="right">0.30</td>
<td align="right">0.30</td>
<td align="right">0</td>
<td align="right">0.37</td>
<td align="right">0.37</td>
</tr>
<tr class="odd">
<td align="right">25</td>
<td align="right">1.0</td>
<td align="right">0.13</td>
<td align="right">0.13</td>
<td align="right">0</td>
<td align="right">0.05</td>
<td align="right">0.05</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">1.0</td>
<td align="right">0.19</td>
<td align="right">0.19</td>
<td align="right">0</td>
<td align="right">0.19</td>
<td align="right">0.17</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">1.0</td>
<td align="right">0.28</td>
<td align="right">0.28</td>
<td align="right">0</td>
<td align="right">0.33</td>
<td align="right">0.33</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">1.0</td>
<td align="right">0.33</td>
<td align="right">0.33</td>
<td align="right">0</td>
<td align="right">0.43</td>
<td align="right">0.42</td>
</tr>
<tr class="odd">
<td align="right">25</td>
<td align="right">3.0</td>
<td align="right">0.23</td>
<td align="right">0.23</td>
<td align="right">0</td>
<td align="right">0.25</td>
<td align="right">0.23</td>
</tr>
<tr class="even">
<td align="right">50</td>
<td align="right">3.0</td>
<td align="right">0.29</td>
<td align="right">0.29</td>
<td align="right">0</td>
<td align="right">0.36</td>
<td align="right">0.35</td>
</tr>
<tr class="odd">
<td align="right">80</td>
<td align="right">3.0</td>
<td align="right">0.35</td>
<td align="right">0.35</td>
<td align="right">0</td>
<td align="right">0.45</td>
<td align="right">0.44</td>
</tr>
<tr class="even">
<td align="right">100</td>
<td align="right">3.0</td>
<td align="right">0.39</td>
<td align="right">0.39</td>
<td align="right">0</td>
<td align="right">0.49</td>
<td align="right">0.51</td>
</tr>
</tbody>
</table>
</div>
<div id="appendix-model-specification" class="section level1">
<h1>Appendix: Model specification</h1>
<div id="combination-blrm-new-study-model" class="section level2">
<h2>Combination BLRM (new study model)</h2>
<p>Let <span class="math inline">\(d_A\)</span> and <span class="math inline">\(d_B\)</span> represent the doses of drugs A and B,
respectively. The dose-toxicity model for the combination expresses the
DLT probability <span class="math inline">\(\pi_{AB}(d_A, d_B)\)</span>
as a function of the doses, through the following model for the DLT
odds</p>
<p><span class="math display">\[ \frac{\pi_{AB}(d_A, d_B)}{1 -
\pi_{AB}(d_A, d_B)} =
\frac{\pi_\perp(d_A, d_B)}{1 - \pi_\perp(d_A, d_B)} \cdot \exp\left\{
2 \eta \frac{(d_A d_B) / (d_A^* d_B^*) }{1 + (d_A d_B) / (d_A^*
d_B^*)}\right\}. \]</span></p>
<p>The two terms on the right-hand side are, respectively, the odds of
DLT under assumed independence of action for the two drugs, i.e.</p>
<p><span class="math display">\[\pi_\perp(d_A, d_B) = 1 - (1 -
\pi_A(d_A))(1 - \pi_B(d_B)) \]</span></p>
<p>and an interaction term which allows for modelling drug toxicity
interactions. See Widmer et al (2023) for a discussion of the
interaction model.</p>
<p>The terms <span class="math inline">\(\pi_A(d_A)\)</span> and <span class="math inline">\(\pi_B(d_B)\)</span> represent the toxicity risk
under each single-agent, respectively, and are modelled with logistic
regression as in Neuenschwander et al (2008):</p>
<p><span class="math display">\[\pi_A(d_A) = \log(\alpha_A) + \beta_A
\log(d_A / d_A^*)\]</span></p>
<p><span class="math display">\[\pi_B(d_B) = \log(\alpha_B) + \beta_B
\log(d_B / d_B^*)\]</span></p>
<p>The model parameters are hence <span class="math inline">\(\alpha_A,
\beta_A, \alpha_B\)</span> and <span class="math inline">\(\beta_B\)</span> (the intercepts and slopes
determining the dose-toxicity curve for the two single agents), and
<span class="math inline">\(\eta\)</span> (controlling the magnitude of
drug toxicity interactions), while <span class="math inline">\(d_A^*\)</span> and <span class="math inline">\(d_B^*\)</span> are fixed pre-specified reference
doses for each drug.</p>
<p>This parametrization is convenient because in many such situations,
relevant information is available to inform prior distributions for the
intercepts and slopes. Specifically, in this example, we have used MAP
priors based on analysis of the historical data under meta-analytic
models.</p>
<div id="prior-specification" class="section level3">
<h3>Prior specification</h3>
<p>For the intercepts and slopes, the MAP priors have the form</p>
<p><span class="math display">\[ (\log \alpha_A, \log \beta_A ) \sim
\sum_{k = 1}^{K_A} w_{Ak} \mbox{BVN}( \mathbf m_{Ak}, \mathbf S_{Ak} ),
\]</span></p>
<p>and</p>
<p><span class="math display">\[ (\log \alpha_B, \log \beta_B ) \sim
\sum_{k = 1}^{K_B} w_{Bk} \mbox{BVN}( \mathbf m_{Bk}, \mathbf S_{Bk} ),
\]</span></p>
<p>where the bivariate normal mixtures have been chosen to approximate
the MAP distribution, i.e.</p>
<div class="sourceCode" id="cb26"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb26-1"><a href="#cb26-1" tabindex="-1"></a>map_mix_A</span></code></pre></div>
<pre><code>## EM for Multivariate Normal Mixture Model
## Log-Likelihood = -4557.01
## 
## Multivariate normal mixture
## Outcome dimension: 2
## Mixture Components:
##                          comp1       comp2      
## w                         0.56206771  0.43793229
## m[intercept]             -1.88227571 -1.52601780
## m[log_slope]              0.59136954  0.01259954
## s[intercept]              0.68030368  0.92524450
## s[log_slope]              0.59829373  0.73241598
## rho[log_slope,intercept] -0.29870546  0.12832698</code></pre>
<p>and</p>
<div class="sourceCode" id="cb28"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb28-1"><a href="#cb28-1" tabindex="-1"></a>map_mix_B</span></code></pre></div>
<pre><code>## EM for Multivariate Normal Mixture Model
## Log-Likelihood = -3252.692
## 
## Multivariate normal mixture
## Outcome dimension: 2
## Mixture Components:
##                          comp1       comp2       comp3      
## w                         0.37748737  0.37130812  0.25120451
## m[intercept]             -2.62052660 -2.62077157 -3.09269497
## m[log_slope]             -0.36785969 -0.78173676 -0.08761646
## s[intercept]              0.42385373  0.66468212  0.66682656
## s[log_slope]              0.40861667  0.51156577  0.40148441
## rho[log_slope,intercept] -0.39229212 -0.05739021 -0.50121005</code></pre>
<p>For the interaction, the prior distribution <span class="math inline">\(\eta \sim \mbox{N}(0,
(\log(9)/1.96)^2)\)</span> was used. This prior is centered at zero
interaction, and 95% of the probability mass falls between DLT odds
multipliers of <span class="math inline">\(1/9\)</span> and <span class="math inline">\(9\)</span> (relative to the no-interaction
model).</p>
</div>
</div>
<div id="meta-analytic-models-for-the-historical-data" class="section level2">
<h2>Meta-analytic models for the historical data</h2>
<p>The MAP approach begins with hierarchical meta-analytic modelling of
the historical data, allowing for the possibility of between-study
heterogeneity.</p>
<p>We describe this model for drug A (drug B being analogous). For
historical studies <span class="math inline">\(h =1 ,\ldots, H\)</span>
(in this case <span class="math inline">\(H=1\)</span>), the DLT
probability for dose <span class="math inline">\(d_A\)</span> is
modelled as</p>
<p><span class="math display">\[ \pi_{Ah}(d_A) = \log \alpha_{Ah} +
\beta_{Ah} \log(d_A / d_A^*). \]</span></p>
<p>Model parameters are assumed to be exchangeable across studies:</p>
<p><span class="math display">\[ (\log \alpha_{Ah}, \log \beta_{Ah})  \,
\, \sim \, \,
\mbox{BVN}\bigl( (\mu_{\alpha A}, \mu_{\beta A}), \boldsymbol \Sigma_A
\bigr) \hspace{20pt} \text{for }h = 1,\ldots, H, \]</span></p>
<p>and to facilitate prediction of the dose-toxicity curve in a new
study, we additionally assume that the study-level parameters for the
new study are exchangeable with those of the historical studies:</p>
<p><span class="math display">\[ (\log \alpha_{A\star}, \log
\beta_{A\star}) \, \, \sim \, \,
\mbox{BVN}\bigl( (\mu_{\alpha A}, \mu_{\beta A}), \boldsymbol \Sigma_A
\bigr). \]</span></p>
<p>Here, <span class="math inline">\(\boldsymbol \Sigma_A\)</span> is a
<span class="math inline">\(2 \times 2\)</span> covariance matrix with
standard deviations <span class="math inline">\(\tau_{\alpha A}\)</span>
and <span class="math inline">\(\tau_{\beta A}\)</span>, and correlation
<span class="math inline">\(\rho_A\)</span>.</p>
<p>This exchangeability assumption allows for posterior estimation of
the MAP distribution for a study-level parameters in a new study, given
historical data:</p>
<p><span class="math display">\[ f(\alpha_{A\star}, \beta_{A\star} |
\mathbf x_{\text{hist}}) = \int f(\alpha_{A\star}, \beta_{A\star} |
\mu_{\alpha A}, \mu_{\beta A}, \tau_{\alpha A}, \tau_{\beta A}, \rho) \,
\, dF(\mu_{\alpha A}, \mu_{\beta A}, \tau_{\alpha A}, \tau_{\beta A} |
\mathbf x_{\text{hist}}). \]</span></p>
<p>The model is completed with normal priors for the means</p>
<p><span class="math display">\[ \mu_{\alpha A} \sim \mbox{N} (
m_{\alpha A}, s^2_{\alpha A}) \]</span> <span class="math display">\[
\mu_{\beta A} \sim \mbox{N} ( m_{\beta A}, s^2_{\beta A}) \]</span></p>
<p>lognormal priors for the standard deviations,</p>
<p><span class="math display">\[ \log \tau_{\alpha A} \sim \mbox{N}(
m_{\tau \alpha A}, s^2_{\tau \alpha A}) \]</span> <span class="math display">\[ \log \tau_{\beta A} \sim \mbox{N}( m_{\tau \beta
A}, s^2_{\tau \beta A}) \]</span></p>
<p>and for the correlation,</p>
<p><span class="math display">\[ \rho_A \sim \mbox{U}(-1, 1).
\]</span></p>
<div id="prior-specification-1" class="section level3">
<h3>Prior specification</h3>
<p>Both models, for drugs A and B, used the same set of
hyper-parameters:</p>
<ul>
<li>Intercept mean and standard deviation:</li>
</ul>
<p><span class="math display">\[m_{\alpha A} = m_{\alpha B} =
\mbox{logit}(0.2)\]</span> <span class="math display">\[s_{\alpha A} =
s_{\alpha B} = 1\]</span></p>
<ul>
<li>Slope mean and standard deviation:</li>
</ul>
<p><span class="math display">\[m_{\beta A} = m_{\beta B} =
\log(1)\]</span> <span class="math display">\[s_{\beta A} = s_{\beta B}
= (\log 4) / 1.96\]</span></p>
<ul>
<li>Heterogeneity standard deviations:</li>
</ul>
<p><span class="math display">\[m_{\tau \alpha A} = m_{\tau \alpha B} =
\log(0.25)\]</span> <span class="math display">\[m_{\tau \beta A} =
m_{\tau \beta B} = \log(0.125)\]</span> <span class="math display">\[s_{\tau \alpha A} = s_{\tau \beta A} = s_{\tau
\alpha B} = s_{\tau \beta B} = (\log 2) / 1.96\]</span></p>
</div>
</div>
<div id="hierarchical-model-for-combined-data-mac" class="section level2">
<h2>Hierarchical model for combined data (MAC)</h2>
<p>The MAC model is a combined model for data from all sources (both
single-agent trials and the planned combination study). Letting <span class="math inline">\(i\)</span> index these sources, the model covers
toxicity of any combination of doses of the two agents:</p>
<p><span class="math display">\[ \frac{\pi_i(d_A, d_B)}{1 - \pi_i(d_A,
d_B)} = \frac{\pi_{\perp, i}(d_A, d_B)}{1 - \pi_{\perp, i}(d_A, d_B)}
\cdot \exp\left\{ 2 \eta_i \frac{(d_A d_B) / (d_A^* d_B^*) }{1 + (d_A
d_B) / (d_A^* d_B^*)}\right\}. \]</span> With, as before</p>
<p><span class="math display">\[\pi_{\perp,i}(d_A, d_B) = 1 - (1 -
\pi_{Ai}(d_A))(1 - \pi_{Bi}(d_B)) \]</span></p>
<p>and <span class="math display">\[ \pi_{Ai}(d_A) = \log(\alpha_{Ai}) +
\beta_{Ai} \log(d_A / d_A^*)\]</span> <span class="math display">\[
\pi_{Bi}(d_B) = \log(\alpha_{Bi}) + \beta_{Bi} \log(d_B /
d_B^*)\]</span></p>
<p>And as before, ex-changeability assumptions facilitate information
borrowing across data sources.</p>
<p><span class="math display">\[ (\log \alpha_{Ai}, \log \beta_{Ai})  \,
\, \sim \, \, \mbox{BVN}\bigl( (\mu_{\alpha A}, \mu_{\beta A}),
\boldsymbol \Sigma_A \bigr) \hspace{20pt} \text{for }i = 1,\ldots, I
\]</span> <span class="math display">\[ (\log \alpha_{Bi}, \log
\beta_{Bi})  \, \, \sim \, \, \mbox{BVN}\bigl( (\mu_{\alpha B},
\mu_{\beta B}), \boldsymbol \Sigma_B \bigr) \hspace{20pt} \text{for }i =
1,\ldots, I \]</span> and</p>
<p><span class="math display">\[ \eta_i \sim \mbox{N}(\mu_\eta,
\tau^2_\eta). \]</span></p>
<p>Priors for the exchangeable means <span class="math inline">\(\mu\)</span> and variances <span class="math inline">\(\tau\)</span> are identical to the meta-analytic
models for the historical single-agent data in the previous section.</p>
</div>
</div>
<div id="session-info" class="section level1">
<h1>Session Info</h1>
<div class="sourceCode" id="cb30"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb30-1"><a href="#cb30-1" tabindex="-1"></a><span class="fu">sessionInfo</span>()</span></code></pre></div>
<pre><code>## R version 4.4.2 (2024-10-31)
## Platform: aarch64-apple-darwin20
## Running under: macOS Sequoia 15.3.2
## 
## Matrix products: default
## BLAS:   /Library/Frameworks/R.framework/Versions/4.4-arm64/Resources/lib/libRblas.0.dylib 
## LAPACK: /Library/Frameworks/R.framework/Versions/4.4-arm64/Resources/lib/libRlapack.dylib;  LAPACK version 3.12.0
## 
## locale:
## [1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8
## 
## time zone: Europe/Zurich
## tzcode source: internal
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tibble_3.2.1     ggplot2_3.5.1    knitr_1.47       tidyr_1.3.1     
## [5] dplyr_1.1.4      posterior_1.6.0  OncoBayes2_0.9-2 RBesT_1.8-1     
## 
## loaded via a namespace (and not attached):
##  [1] gtable_0.3.5          tensorA_0.36.2.1      xfun_0.45            
##  [4] bslib_0.7.0           QuickJSR_1.2.2        inline_0.3.19        
##  [7] vctrs_0.6.5           tools_4.4.2           generics_0.1.3       
## [10] stats4_4.4.2          curl_5.2.1            parallel_4.4.2       
## [13] fansi_1.0.6           highr_0.11            pkgconfig_2.0.3      
## [16] checkmate_2.3.1       RColorBrewer_1.1-3    distributional_0.4.0 
## [19] RcppParallel_5.1.7    assertthat_0.2.1      lifecycle_1.0.4      
## [22] stringr_1.5.1         farver_2.1.2          compiler_4.4.2       
## [25] textshaping_0.4.0     munsell_0.5.1         codetools_0.2-20     
## [28] htmltools_0.5.8.1     sass_0.4.9            bayesplot_1.11.1     
## [31] yaml_2.3.8            Formula_1.2-5         pillar_1.9.0         
## [34] jquerylib_0.1.4       cachem_1.1.0          StanHeaders_2.32.9   
## [37] abind_1.4-5           rstan_2.32.6          tidyselect_1.2.1     
## [40] digest_0.6.35         stringi_1.8.4         mvtnorm_1.2-5        
## [43] reshape2_1.4.4        purrr_1.0.2           labeling_0.4.3       
## [46] fastmap_1.2.0         grid_4.4.2            colorspace_2.1-0     
## [49] cli_3.6.2             magrittr_2.0.3        loo_2.7.0            
## [52] pkgbuild_1.4.4        utf8_1.2.4            withr_3.0.0          
## [55] scales_1.3.0          backports_1.5.0       rmarkdown_2.29       
## [58] matrixStats_1.3.0     gridExtra_2.3         ragg_1.3.2           
## [61] evaluate_0.24.0       V8_4.4.2              rstantools_2.4.0.9000
## [64] rlang_1.1.4           isoband_0.2.7         Rcpp_1.0.12          
## [67] glue_1.7.0            jsonlite_1.8.8        plyr_1.8.9           
## [70] R6_2.5.1              systemfonts_1.1.0</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
